Drugs that contain Estradiol

1. List of Elestrin drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7198801 MYLAN SPECIALITY LP Formulations for transdermal or transmucosal application
Jun, 2022

(7 months ago)

Market Authorisation Date: 15 December, 2006

Treatment: NA

Dosage: GEL, METERED;TRANSDERMAL

More Information on Dosage

2. List of Evamist drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6978945 PADAGIS US Dispensing device
Jul, 2022

(5 months ago)

Market Authorisation Date: 27 July, 2007

Treatment: NA

Dosage: SPRAY;TRANSDERMAL

More Information on Dosage

3. List of Imvexxy drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11497709 THERAPEUTICSMD INC NA
Nov, 2032

(9 years from now)

US10537581 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US11246875 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US11241445 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US10835487 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US9289382 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US10806697 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US11351182 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US11304959 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US10888516 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion
Jun, 2033

(10 years from now)

US11123283 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion
Jun, 2033

(10 years from now)

US10668082 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Jun, 2033

(10 years from now)

US10568891 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Jun, 2033

(10 years from now)

US10471072 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Jun, 2033

(10 years from now)

US11116717 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion
Jun, 2033

(10 years from now)

US11065197 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion
Jun, 2033

(10 years from now)

US10398708 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Dec, 2033

(10 years from now)

US10258630 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Dec, 2033

(10 years from now)

US9180091 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion
Dec, 2033

(10 years from now)

US11266661 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Feb, 2034

(11 years from now)

Market Authorisation Date: 29 May, 2018

Treatment: Treatment of dyspareunia; Treatment of a symptom of vulvar and vaginal atrophy; Treatment of moderate to severe dyspareunia

Dosage: INSERT;VAGINAL

How can I launch a generic of IMVEXXY before it's patent expiration?
More Information on Dosage

4. List of Minivelle drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9724310 NOVEN Transdermal estrogen device and delivery
Jul, 2028

(5 years from now)

US8231906 NOVEN Transdermal estrogen device and delivery
Jul, 2030

(7 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9833419 NOVEN Transdermal estrogen device and delivery
Jul, 2028

(5 years from now)

US9730900 NOVEN Transdermal estrogen device and delivery
Jul, 2028

(5 years from now)

Market Authorisation Date: 29 October, 2012

Treatment: A method for administering estradiol comprising a monolithic transdermal drug delivery system consisting of (i) a backing layer and (ii) a single adhesive polymer matrix layer as claimed in us patent no. 9730900

Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL

How can I launch a generic of MINIVELLE before it's patent expiration?
More Information on Dosage

5. List of Vagifem drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7018992 NOVO NORDISK INC Hormone composition
Sep, 2022

(4 months ago)

Market Authorisation Date: 26 March, 1999

Treatment: Treatment of atrophic vaginitis due to menopause

Dosage: TABLET;VAGINAL

How can I launch a generic of VAGIFEM before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in